Ginkgo Bioworks(DNA.US) Director Buys US$514.75K in Common Stock

$Ginkgo Bioworks(DNA.US)$ Director Sankar Shyam purchased 625K shares of common stock on May 15, 2024 at an average price of $0.8236 for a total value of $514.75K.Source: Announcement What is statemen

Futu NewsMay 16 16:52

Form 144 | Ginkgo Bioworks(DNA.US) Director Proposes to Sell 220.03K in Common Stocks

SEC FILLINGS DISCLOSED/ May 16, $Ginkgo Bioworks(DNA.US)$ Director Novalis LifeSciences Investments I, L.P. intends to sell 265K shares of its common stock on May 16, with a total market value of appr

Futu NewsMay 16 16:18

Ginkgo Bioworks Holdings Insider Bought Shares Worth $514,750, According to a Recent SEC Filing

Shyam Sankar, Director, on May 15, 2024, executed a purchase for 625,000 shares in Ginkgo Bioworks Holdings (DNA) for $514,750. Following the Form 4 filing with the SEC, Sankar has control over a tota

MT NewswiresMay 16 16:11

BTIG: Downgraded Ginkgo Bioworks Holdings (DNA.US) rating from neutral to selling.

BTIG: Downgraded Ginkgo Bioworks Holdings (DNA.US) rating from neutral to selling.

Zhitong FinanceMay 15 12:02

Ginkgo Slips as BTIG Cuts to Sell on Strategic Shift

Seeking AlphaMay 15 09:45

Morgan Stanley Maintains Equal-Weight on Ginkgo Bioworks Holdings, Lowers Price Target to $1

Morgan Stanley analyst Tejas Savant maintains Ginkgo Bioworks Holdings with a Equal-Weight and lowers the price target from $2 to $1.

Analyst UpgradesMay 15 09:25